Digital Pathology Market Outlook 2030: Industry Insights & Opportunity Evaluation, 2019-2030

$5,000$10,000

Digital Pathology Market to surpass USD 1,492 million by 2030 from USD 510 million in 2019 at a CAGR of 13.5% throughout the forecast period, i.e., 2020-30.

Clear

Description

Digital Pathology Market: Market Segments: By Product (Software, Scanner, Communication Systems, Storage Systems); By Application (Disease Diagnosis, Teleconsultation, Drug Discovery, Training & Education); By End User (Pharmaceutical & Biotechnology Companies, Hospitals and Clinics, Academics Institutes & Research Laboratories); and Region – Global Analysis of Market Size, Share & Trends for 2014 – 2020 and Forecasts to 2030
Product Overview
Digital pathology requires digital format management, sharing, acquisition, and interpretation of pathology content. With a scanning system that offers a high-resolution digital image, glass slides are scanned. On a computer or mobile device, this visual image is then displayed. Technologically advanced optical pathology scanners, which can capture high quality images of whole glass slides, are available on the market.
Market Highlights
Digital Pathology Market is expected to project a notable CAGR of 13.5% in 2030.
Digital Pathology Market to surpass USD 1,492 million by 2030 from USD 510 million in 2019 at a CAGR of 13.5% throughout the forecast period, i.e., 2020-30. The main factors driving the growth of the global digital pathology market are some of the primary factors, such as the efficient cost of digital pathology products, the ease of virtual transport of slides, and the high performance of digital pathology systems.
Digital Pathology Market: Segments
Diseases diagnosis segment to grow with the highest CAGR of 12.3% during 2020-30
Digital Pathology Market is segmented by applications as drug discovery, teleconsultation, training & education, and diseases diagnosis. Based on application, the teleconsultation segment held the leading position with a market share of around XX.X% in the Digital Pathology market in 2019 as digital pathology is being widely utilized for consulting the geriatric population.
Digital Pathology Market: Market Dynamics
Drivers
Growing Number of Tele-consultations
Teleconsultation seeks to omit the spatial and practical gaps between two or more providers of healthcare that are geographically isolated. It is characterized as remote telecommunications consultation, primarily for the diagnosis or treatment of a patient at locations that are distant from patients or primary doctors. Several hospitals, primary healthcare doctors, private medical practices, and other medical units are introducing teleconsultation facilities.
Restrain
High cost of digital pathology systems
The development of the digital pathology market is hindered by uncertain reimbursement policies, shortages of trained staff, and the reluctance of older pathologists to embrace modern technologies. While these systems can be afforded by large hospitals with substantial capital budgets, pathologists and academic institutions with small budgets or IT support often cannot afford them.
Digital Pathology Market: Regions
Digital Pathology Market is segmented based on regional analysis into five major regions. These include North America, Latin America, Europe, APAC and MENA.
Digital Pathology Market in North America held the largest market share of XX.X% in the year 2019 and it is expected to continue its market dominance in the future owing to the continuous implementation of R&D investments, supportive government policies related to the production of technologically advanced technologies, increased use of digital imaging, and the participation of major players. The regional growth is expected to be further fueled by increased use of digital pathology for disease diagnosis coupled with favorable reimbursement policies in the U.S., improving the efficiency of cancer diagnosis. Due to the increasing penetration of digital imaging in emerging economies, investments in the medical sector, and the existence of untapped opportunities, Asia Pacific is expected to grow at the fastest CAGR during the forecast period. Because of the increased prevalence of cancer, which affects a large population, the Asia Pacific healthcare industry has greatly affected the market. Increasing demand for new treatment options, improved care facilities for patients, and lower laboratory costs are also expected to further drive the demand in coming years.
Digital Pathology Market: Key Players
• 3DHistech Ltd
Company Overview, Business Strategy, Key Product Offerings, Financial Performance, Key Performance Indicators, Risk Analysis, Recent Development, Regional Presence and SWOT Analysis.
• Hamamatsu Photonics KK
• Danaher Corporation (Leica Biosystems Nussloch GmbH)
• Mikroscan Technologies Inc.
• Nikon Corporation
• Olympus Corporation
• Koninklijke Philips NV
• F. Hoffmann-La Roche AG (Ventana Medical Systems Inc.)
• Visiopharm AS
• Proscia Inc.
• Sectra AG
Digital Pathology Market report also contains analysis on:
Digital Pathology Market Segments:
By Product:
• Software
• Scanner
• Communication Systems
• Storage Systems
By Application:
• Disease Diagnosis
• Teleconsultation
• Drug Discovery
• Training & Education
By End-User:
• Pharmaceutical & Biotechnology Companies
• Hospitals and Clinics
• Academics Institutes & Research Laboratories

• Digital Pathology Market Dynamics
• Digital Pathology Market Size
• Supply & Demand
• Current Trends/Issues/Challenges
• Competition & Companies Involved in the Market
• Value Chain of the Market
• Market Drivers and Restraints
FAQs on Digital Pathology Market
· Which segment is anticipated to hold the largest market share?
· At what CAGR is the market anticipated to grow between 2020 and 2030?
· Who are the key players in the Digital Pathology Market?
· What could be the challenging factors in the growth of Digital Pathology Market?
· What are the growth drivers for the Digital Pathology Market?

Additional information

Publisher

Geography Covered

Date Published

,

Pages

Format

Table of Contents

Contents
1. Executive Summary
2. Digital Pathology Market
2.1. Product Overview
2.2. Market Definition
2.3. Segmentation
2.4. Assumptions and Acronyms
3. Research Methodology
3.1. Research Objectives
3.2. Primary Research
3.3. Secondary Research
3.4. Forecast Model
3.5. Market Size Estimation
4. Average Pricing Analysis
5. Macro-Economic Indicators
6. Market Dynamics
6.1. Growth Drivers
6.2. Restraints
6.3. Opportunity
6.4. Trends
7. Correlation & Regression Analysis
7.1. Correlation Matrix
7.2. Regression Matrix
8. Recent Development, Policies & Regulatory Landscape
9. Risk Analysis
9.1. Demand Risk Analysis
9.2. Supply Risk Analysis
10. Digital Pathology Analysis
10.1. Porters Five Forces
10.1.1. Threat of New Entrants
10.1.2. Bargaining Power of Suppliers
10.1.3. Threat of Substitutes
10.1.4. Rivalry
10.2. PEST Analysis
10.2.1. Political
10.2.2. Economic
10.2.3. Social
10.2.4. Technological
11. Digital Pathology Market
11.1. Market Size & forecast, 2019A-2030F
11.1.1. By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
11.1.2. By Volume (Million Units) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12. Digital Pathology: Market Segmentation
12.1. By Regions
12.1.1. North America:
• By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12.1.2. Europe:
• By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12.1.3. Asia-Pacific:
• By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12.1.4. MEA:
• By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12.1.5. Latin America:
• By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12.2. By Product: Market Share (2020-2030F)
12.2.1. Software, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12.2.2. Scanner, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12.2.1. Communication Systems, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12.2.2. Storage Systems, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12.3 By Application: Market Share (2020-2030F)
12.3.1. Disease Diagnosis, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12.3.2. Teleconsultation, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12.3.3. Drug Discovery, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12.3.3. Training & Education, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12.4 By End User: Market Share (2020-2030F)
12.4.1. Pharmaceutical & Biotechnology Companies, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12.4.2. Hospitals and Clinics, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12.4.3. Academics Institutes & Research Laboratories, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
13. Company Profile
13.1.1. 3DHistech Ltd
13.1.2. Company Overview
13.1.3. Company Total Revenue (Financials)
13.1.4. Market Potential
13.1.5. Global Presence
13.1.6. Key Performance Indicators
13.1.7. SWOT Analysis
13.1.8. Product Launch
13.2. Hamamatsu Photonics KK
13.3. Danaher Corporation (Leica Biosystems Nussloch GmbH)
13.4. Mikroscan Technologies Inc.
13.5. Nikon Corporation
13.6. Olympus Corporation
13.7. Koninklijke Philips NV
13.8. F. Hoffmann-La Roche AG(Ventana Medical Systems Inc.)
13.9. Visiopharm AS
13.10. Proscia Inc.
13.11. Sectra AG

14 Consultant Recommendation
**The above given segmentations and companies could be subjected to further modification based on in-depth feasibility studies conducted for the final deliverable.

RSS
Follow by Email